Citation Impact
Citing Papers
Secular Trends in Incidence of Atrial Fibrillation in Olmsted County, Minnesota, 1980 to 2000, and Implications on the Projections for Future Prevalence
2006 Standout
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
2009 Standout
Thiazolidinediones
2004 Standout
Effect of pravastatin on frequency of fracture in the LIPID study: secondly analysis of a randomised controlled trial
2001
Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist
1999 Standout
Osteoporosis
2019 Standout
Estrogen receptors and human disease
2006 Standout
Testosterone Therapy in Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline
2010 Standout
Acute effect of pamidronate on PTH secretion in postmenopausal hemodialysis patients with secondary hyperparathyroidism
2003
Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With Raloxifene<SUBTITLE>Results From a 3-Year Randomized Clinical Trial</SUBTITLE>
1999 Standout
Metabolic effects of pamidronate in patients with metastatic bone disease
1996
Exercise Effects on Bone Mineral DensityRelationships to Changes in Fitness and Fatness
2005
Effects of Risedronate Treatment on Vertebral and Nonvertebral Fractures in Women With Postmenopausal Osteoporosis<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
1999 Standout
Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline
2011 Standout
Diagnosis of osteoporosis and assessment of fracture risk
2002 Standout
Effect of Calcium and Vitamin D Supplementation on Bone Density in Men and Women 65 Years of Age or Older
1997 Standout
Cushing's syndrome
2015 Standout
Adverse Effects of Testosterone Therapy in Adult Men: A Systematic Review and Meta-Analysis
2010 Standout
The Protective Effects of Estrogen on the Cardiovascular System
1999 Standout
The Role of Parathyroid Hormone in the Pathogenesis of Glucocorticoid-Induced Osteoporosis: A Re-Examination of the Evidence
2002
The Epidemiology of Corticosteroid-Induced Osteoporosis: a Meta-analysis
2002
Vitamin D Deficiency
2007 Standout
Obesity in older adults: technical review and position statement of the American Society for Nutrition and NAASO, The Obesity Society
2005
A UK Consensus Group on management of glucocorticoid‐induced osteoporosis: an update
1998
Effective Doses in Radiology and Diagnostic Nuclear Medicine: A Catalog
2008 Standout
Impracticability of Informed Consent in the Registry of the Canadian Stroke Network
2004 Standout
Bone Quality — The Material and Structural Basis of Bone Strength and Fragility
2006 Standout
Increased bone mass with pamidronate treatment in rheumatoid arthritis. Results of a three‐year randomized, double‐blind trial
1996
Overweight, Obesity, and Mortality in a Large Prospective Cohort of Persons 50 to 71 Years Old
2006 Standout
Treatment of Postmenopausal Osteoporosis
1998
Guidance for the management of breast cancer treatment-induced bone loss: A consensus position statement from a UK Expert Group
2008
Treatment of postmenopausal osteoporosis
2002
Intravenous bisphosphonate prevents symptomatic osteoporotic vertebral collapse in patients after liver transplantation
1998
Effects of Raloxifene on Bone Mineral Density, Serum Cholesterol Concentrations, and Uterine Endometrium in Postmenopausal Women
1997 Standout
WNT signaling in bone homeostasis and disease: from human mutations to treatments
2013 Standout
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Effects of oral alendronate and intranasal salmon calcitonin on bone mass and biochemical markers of bone turnover in postmenopausal women with osteoporosis
1995
Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures
1996 Standout
The Role of Knee Alignment in Disease Progression and Functional Decline in Knee Osteoarthritis
2001 Standout
Diagnosis and Complications of Cushing’s Syndrome: A Consensus Statement
2003 Standout
Inhibitory action of bisphosphonates on bone resorption does not involve the regulation of RANKL and OPG expression
2002
Geographic trends in incidence of hip fractures: a comprehensive literature review
2011
Osteoclast differentiation and activation
2003 StandoutNature
T Lymphocytes Amplify the Anabolic Activity of Parathyroid Hormone through Wnt10b Signaling
2009
Age Trends in the Level of Serum Testosterone and Other Hormones in Middle-Aged Men: Longitudinal Results from the Massachusetts Male Aging Study
2002 Standout
Advances in estrogen receptor biology: prospects for improvements in targeted breast cancer therapy
2003
Effect of Alendronate on Risk of Fracture in Women With Low Bone Density but Without Vertebral Fractures<SUBTITLE>Results From the Fracture Intervention Trial</SUBTITLE>
1998 Standout
Global strategy for asthma management and prevention: GINA executive summary
2007 Standout
Management of patients on chronic glucocorticoid therapy: an endocrine perspective
2003
The role of dual energy X-rayabsorptiometry of lumbar spine and proximal femur in the diagnosis and follow-up of osteoporosis
1995
Molecular basis of agonism and antagonism in the oestrogen receptor
1997 StandoutNature
Cushing's syndrome
2006 Standout
Glucocorticoid-induced osteoporosis
2000
Epidemiology and outcomes of osteoporotic fractures
2002 Standout
Selective Estrogen-Receptor Modulators — Mechanisms of Action and Application to Clinical Practice
2003
Frailty in elderly people
2013 Standout
Prevention of falls and consequent injuries in elderly people
2005 Standout
Inflammatory bone loss: pathogenesis and therapeutic intervention
2012 Standout
Effects of Raloxifene on Serum Lipids and Coagulation Factors in Healthy Postmenopausal Women
1998
Bone Density in an Immigrant Population from Southeast Asia
2001
The Complex Role of Estrogens in Inflammation
2007 Standout
Femoral bone loss progresses with age: A longitudinal study in women over age 65
1994
(Z)-Tamoxifen and Tetrasubstituted Alkenes and Dienes via a Regio- and Stereospecific Three-Component Magnesium Carbometalation Palladium(0) Cross-Coupling Strategy
2003
Testosterone Therapy in Glucocorticoid-Treated Men
1996
Selective Estrogen-Receptor Modulators for Primary Prevention of Breast Cancer
2005
Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritis.
1995
Exercise and Physical Activity for Older Adults
2009 Standout
Noninvasive assessment of bone mineral and structure: State of the art
1996
Vitamin D Repletion in Patients with Primary Hyperparathyroidism and Coexistent Vitamin D Insufficiency
2005
The Endocrinology of Aging
1997 Science
The Sonogashira Reaction: A Booming Methodology in Synthetic Organic Chemistry
2007 Standout
The Epidemiology of Osteoporosis
1996
Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis*
1997 Standout
From Density to Structure: Growing Up and Growing Old on the Surfaces of Bone
1997
Osteoporosis Is More Prevalent in Adrenal than in Pituitary Cushing's Syndrome.
2003
Mechanisms of Estrogen Action
2001 Standout
Systematic Review: Comparative Effectiveness of Treatments to Prevent Fractures in Men and Women with Low Bone Density or Osteoporosis
2008
The epidemiology of osteoporosis. The oriental perspective in a world context.
1996
Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis*
2000 Standout
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
2005 Standout
Glucocorticoid Osteoporosis
1999
The Role of CBP in Estrogen Receptor Cross-Talk with Nuclear Factor-κB in HepG2 Cells
2000
A Test of Pre–Main‐Sequence Evolutionary Models across the Stellar/Substellar Boundary Based on Spectra of the Young Quadruple GG Tauri
1999 StandoutNobel
Normal ranges for vertebral height ratios and prevalence of vertebral fracture in hong kong chinese: A comparison with American caucasians
1996
From Estrogen-Centric to Aging and Oxidative Stress: A Revised Perspective of the Pathogenesis of Osteoporosis
2010 Standout
A controlled trial of raloxifene (LY139481) HCl: Impact on bone turnover and serum lipid profile in healthy postmenopausal women
1996
Current methods and advances in bone densitometry
1995
Skeletal complications of malignancy
1997 Standout
A Role for Interleukin-6 in Parathyroid Hormone-Induced Bone Resorption in Vivo1
1999
Who Has Osteoporosis? A Conflict Between Clinical and Public Health Perspectives
2000
Bone Density and Fracture Risk in Men
1998
Selective Estrogen Receptor Modulators: Clinical Spectrum*
1999
A Transmembrane Intracellular Estrogen Receptor Mediates Rapid Cell Signaling
2005 StandoutScience
Free Radicals in the Physiological Control of Cell Function
2002 Standout
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
2002 Standout
Bisphosphonates: Mechanisms of Action
1998
Current methods and advances in bone densitometry
1995
Works of J P Stapleton being referenced
The effect of the antiestrogen tamoxifen on bone mineral density in normal late postmenopausal women
1995
Accelerated bone loss in post‐menopausal women with mild primary hyperparathyroidism
1996
Lateral Bone Densitometry Is a More Sensitive Indicator of Glucocorticoid-Induced Bone Loss
1993
Continuous therapy with pamidronate, a potent bisphosphonate, in postmenopausal osteoporosis.
1994
Sources of interracial variation in bone mineral density
1995
Circulating insulin levels are related to bone density in normal postmenopausal women
1993
The effect of the anti-estrogen tamoxifen on cardiovascular risk factors in normal postmenopausal women.
1995
Regular exercise dissociates fat mass and bone density in premenopausal women.
1995
Lateral spine densitometry is a more sensitive indicator of glucocorticoid-induced bone loss
1992